Navigation Links
Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
Date:4/8/2008

SHANGHAI, China, April 8, 2008 /Xinhua-PRNewswire-FirstCall/ -- Linkwell Corporation (Linkwell or the Company) (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, today announced it will discuss its 2007 year-end financial results in a conference call on Wednesday, April 16, 2008, at 8:30 a.m. EDT.

The Company will release its 2007 year-end financial results on Tuesday, April 15, 2008. Hosting the call will be Linkwell Chairman and CEO Xuelian Bian, COO Arthur Huang, Corporate Secretary Rick Wang and investor relations consultant Craig Bird.

Conference Call

To participate in the conference call, callers from the USA and Canada please dial 800-257-2101, all other international callers please dial (303)-262-2130. All callers should dial in five to ten minutes prior to the conference call time.

Audio Stream and Webcast

You may also participate via live audio stream by logging onto http://www.investquest.com/iq/l/linkwell/ . A rebroadcast of the audio stream will be available using the same web link for 90 days after the initial broadcast.

Linkwell also announced the revised dates for its non-deal road show in the USA to April 16-22, 2008. Investors interested in meeting with Linkwell COO, Mr. Arthur Huang should contact investor relations, Craig Bird, at (215)-885-4981.

About Linkwell Corporation

Linkwell Corporation develops, manufactures and distributes disinfectant healthcare products in China through its subsidiary Shanghai LiKang Disinfectant High Tech Company ("LiKang"). Linkwell's disinfectant healthcare products are a nationally recognized domestic Chinese brand in this market segment. Linkwell products include disinfectants in liquid, tablet, powder and aerosol form. Through LiKang, Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. For more information, please visit http://www.linkwell.us .

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the Company's operations, financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The Company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, but not limited to, the impact of competitive products, pricing and new technology; changes in consumer preferences and tastes; effectiveness of marketing; changes in laws and regulations; fluctuations in costs of production; and other factors as those discussed in the Company's reports filed with the Securities and Exchange Commission from time to time. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Investor Relations

Craig Bird

Segue Ventures LLC

Tel: +1-215-885-4981

Email: chbird@segue.biz


'/>"/>
SOURCE Linkwell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Linkwell Corp to File to Extend Filing Date for 2007 Form 10-K
2. Shanghai Disinfection Association and Linkwell Corporation Co-Establish the Shanghai Disinfection Association Laboratory Center
3. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
4. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
5. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 8:00am ET
6. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
7. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET
8. Pet DRx Corporation Reports 2007 Financial Results
9. Dialysis Corporation of America Announces the Development of a New Facility in Pennsylvania
10. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
11. Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: